Pfizer And Astellas Say Phase 3 EMBARK Study Of XTANDI To Treat Prostate Cancer Meets Primary Goal

Pfizer Inc. (PFE) and Astellas Pharma Inc. (ALPMY) Thursday said Phase 3 EMBARK study of XTANDI for the treatment of prostate cancer met its primary goal.

EMBARK study enrolled 1,068 patients with non-metastatic castration-sensitive prostate cancer (nmCSPC) and high-risk biochemical recurrence (BCR). They were randomized to one of three study arms- XTANDI plus leuprolide, placebo plus leuprolide, or XTANDI monotherapy.

Topline results from the study showed that XTANDI plus leuprolide significantly improved metastasis-free survival in men with non-metastatic prostate cancer, Astellas said.

"The topline findings from EMBARK are highly encouraging and we look forward to engaging with health authorities to potentially bring XTANDI to men with non-metastatic hormone sensitive prostate cancer and high-risk biochemical recurrence." said Chris Boshoff, Chief Development Officer, Oncology and Rare Disease, Pfizer Global Product Development.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Paterson, New Jersey - based E.N.A. Meat Packing Inc. is recalling around 39,947 pounds of frozen, raw lamb products that were imported without the benefit of import reinspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The products subject to recall include cartons weighing around 40-lb., containing raw frozen pieces of "Simunovic S.A. Frozen Bon Retailers Macy's, Inc. (M) and Dollar General Corp. (DG) reported on Thursday that net profits for the first quarter declined from last year, with Macy's topping estimates, while Dollar General missed it. Net sales at both retailers missed expectations. Both Macy's and Dollar General also slashed their guidance for the full-year 2023. The U.S. Food and Drug Administration has warned certain retailers against unauthorized sales of popular disposable e-cigarettes, mainly various types of Puff and Hyde brand e-cigarettes. Under the retailer inspection blitz, warning letters have been issued to 30 retailers, including one distributor, for illegally selling such products. All products cited in the warning letters are disposable
Follow RTT